Coave Therapeutics: redecorating viral vectors for improved gene therapies Coave Therapeutics is a French biotech developing gene therapies for neurodegenerative and ocular diseases. The company has developed a technology […] January 25, 2023 · V-Bio Ventures
Great at small things: BCCM stores microorganisms, plasmids, hybridomas, and more! BCCM is a Belgian non-profit consortium of seven biological resource centers preserving and distributing microbial and genetic resources, offering storage […] December 14, 2022 · Turnstone Communications
Marfan patients team up with researchers to catch their silent killer The world’s undiagnosed Marfan patients often go through life unaware of the hidden killer lurking in their DNA – a […] November 23, 2022 · SciMingo
Is Belgium becoming a hub for gene therapy? Ghent, Belgium, 10 November 2022 – Gene therapy provides solutions to deadly diseases. Is the technology ready for a big […] November 10, 2022 · Turnstone Communications
Gene therapy challenges and the solutions in sight Dr. Federico Mingozzi is the CSO of Spark Therapeutics, the company behind Luxturna – the world’s first FDA-approved gene therapy […] October 19, 2022 · BioVox
Gene therapy pioneer Dr. Katherine High on the past and future of the field Dr. Katherine High is one of gene therapy’s pioneers, who has contributed to a long list of firsts in the […] August 17, 2022 · BioVox
Genetic blindness: shining a light on Stargardt for future cures The arrival of gene therapy in the ‘90s brought hope for the treatment of genetic diseases. In recent years, new […] April 20, 2022 · SciMingo
CRISPR takes the ‘bitter’ out of Belgian endives and chicory Researchers have identified the bitter substances in Belgian endives and chicory. Using the gene-editing technique CRISPR/Cas9, they have also succeeded […] February 16, 2022 · BioVox
New start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and faster Ghent, Belgium, 6 December 2021 – Trince, a spin-off of Ghent University (UGent), is developing innovative and efficient technology to insert […] December 6, 2021 · Turnstone Communications
Rejuvenate Biomed: Expanding peoples’ health spans by boosting cell resilience Aging will affect each and every one of us at some point; it is part of the covenant of life. […] November 24, 2021 · Turnstone Communications
New GMOs on the horizon: say ‘cheese’! To meet the challenges of climate change and global food demand, more VCs are investing in AgTech companies. A lot […] October 20, 2021 · V-Bio Ventures
The dark matter of the genome: Flamingo Therapeutics taps potential of mysterious RNA for cancer therapies Things are moving fast for Flamingo Therapeutics, a Leuven-based biotech company developing innovative RNA-targeted cancer therapies. The start-up is a […] October 20, 2021 · BioVox
Betting on the best egg: Aurora test doubles pregnancy chances in assisted conception Assisted conception techniques have matured in the last few decades, with Belgian scientists playing a big part in the progress. […] August 18, 2021 · BioVox
Newton Biocapital invests in EditForce to support development of a unique DNA/RNA editing platform based on PPR protein technology Brussels, Belgium / Tokyo, Japan – 1 July 2021 – Newton Biocapital (“Newton”), a life sciences investment fund active in […] July 1, 2021 · Turnstone Communications
Droia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski Brussels, Belgium, 11 May 2021 – Droia Ventures today announced the final closing of its third fund, having raised EUR […] May 11, 2021 · Turnstone Communications